Intrust Bank’s Medpace MEDP Stock Holding History

Intrust Bank’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,529	Closed	-$251K	–	386
2021 Q1	$251K	Sell	1,529 -421	-22%	-$64.4K	0.04%	330
2020 Q4	$272K	Sell	1,950 -18	-0.9%	-$2.27K	0.04%	305
2020 Q3	$220K	Buy	+1,968	New	+$228K	0.04%	307

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Intrust Bank's MEDP Position: Q2 2021 in Review

Intrust Bank sold out of Medpace (MEDP) in Q2 2021, closing a stake of 1,529 shares — an estimated $251K sold.

Intrust Bank first reported a position in MEDP in Q3 2020 and held it in 3 quarters. The position peaked at $272K in Q4 2020. 324 funds tracked by Wall St. Rank hold MEDP as of Q2 2021.

Intrust Bank reported no remaining Medpace position as of Q2 2021 after selling out during the quarter.
Intrust Bank sold 1,529 Medpace shares in Q2 2021, an estimated $251K.
Intrust Bank first reported a position in Medpace in Q3 2020 and held it in 3 quarters.
Intrust Bank's Medpace position peaked at $272K in Q4 2020.
324 funds tracked by Wall St. Rank held Medpace as of Q2 2021.

Based on Intrust Bank's 13F filing for Q2 2021, filed 5 Aug 2021.